Showing 1 - 5 results of 5 for search 'Domenico Mallardo', query time: 0.01s
Refine Results
-
1
Metabolomic signatures in liquid biopsy are associated with overall survival in metastatic melanoma patients treated with immune checkpoint inhibitor therapy by Susan Costantini, Gabriele Madonna, Mariaelena Capone, Elena Di Gennaro, Palmina Bagnara, Federica Renza, Domenico Mallardo, Roberta Affatato, Carlo Vitagliano, Marilena Romanelli, Marilena Tuffanelli, Ester Simeone, Gennaro Ciliberto, Paolo A. Ascierto, Alfredo Budillon
Published 2025-04-01Get full text
Article -
2
The combination of body mass index and serum creatinine levels predicts survival in patients with Hodgkin lymphoma treated with nivolumab in the CheckMate 205 study by Rosaria De Filippi, Fortunato Morabito, Giovanni Tripepi, Stephen M. Ansell, Sara Mele, Emanuela Morelli, Domenico Mallardo, Daniela Donnarumma, Francesco Volzone, Alev Akyol, Annarosa Cuccaro, Mariangela Saggese, Matteo Bonanni, Maria Esposito, Stefania Crisci, Pier Luigi Zinzani, Antonio Pinto
Published 2025-12-01Get full text
Article -
3
PARP inhibitors in testicular germ cell tumors: what we know and what we are looking for by Sara Parola, Christoph Oing, Pasquale Rescigno, Salvatore Feliciano, Francesca Carlino, Luca Pompella, Antonella Lucia Marretta, Irene De Santo, Martina Viggiani, Margherita Muratore, Bianca Arianna Facchini, Jessica Orefice, Eleonora Cioli, Francesca Sparano, Domenico Mallardo, Ugo De Giorgi, Giovannella Palmieri, Paolo Antonio Ascierto, Margaret Ottaviano
Published 2024-11-01Get full text
Article -
4
Gene-expression signature predicts autoimmune toxicity in metastatic melanoma by Michael Bailey, Andrew White, Francesca Sparano, Alessandra Cesano, Mariaelena Capone, Corrado Caracò, Ester Simeone, Lucia Festino, Alfredo Budillon, Sarah Warren, Domenico Mallardo, Paolo A Ascierto, Vito Vanella, Ernesta Cavalcanti, Claudia Trojaniello, Maria Grazia Vitale, Margaret Ottaviano, Paolo Chiodini, Mario Fordellone, Bianca Arianna Facchini, Maria Ingenito, Caterina Costa, Rosaria De Filippi
Published 2025-07-01Get full text
Article -
5
Serum CD73 is a prognostic factor in patients with metastatic melanoma and is associated with response to anti-PD-1 therapy by Dirk Schadendorf, Celeste Lebbe, Teresa Amaral, Benjamin Weide, Mariaelena Capone, Gabriele Madonna, Lucia Festino, Reinhard Dummer, Domenico Mallardo, Paolo A Ascierto, Piotr Rutkowski, Jason John Luke, Kilian Wistuba-Hamprecht, Mitchell P Levesque, Roberta Turiello, Elva Morretta, Maria Chiara Monti, Rosa Azzaro, Laurence Imhof, Marc Chevrier, Antje Sucker, Aldo Pinto, Silvana Morello
Published 2020-10-01Get full text
Article